A/s Novo, 10% Owner at Tobira Therapeutics, Inc. (TBRA), sold 92,119 shares at $12.57 ($1.1M) on 2016-07-05, disclosed to the SEC on 2016-07-07.
Open-market sale of $1.1M TBRA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.57 | 10,400 | $131K | 11.6% |
| 2 | $12.20 | 59,850 | $730K | 65.0% |
| 3 | $12.03 | 21,869 | $263K | 23.4% |
| Total | $12.20 avg | 92,119 | $1.1M | 100% |
| Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $582K | — | Filing → |
| OPHT | SELL | 2016-12-16 | $17.6M | — | Filing → |